Emerging therapies for relapsing multiple sclerosis
- PMID: 19597083
- DOI: 10.1001/archneurol.2009.104
Emerging therapies for relapsing multiple sclerosis
Abstract
Six agents are currently approved by regulatory agencies to treat relapsing multiple sclerosis. Although these agents are effective and generally safe, some patients have continued disease activity or adverse effects. A sizable number of new agents are under investigation currently. This article reviews emerging agents that have shown promise in phase 2 trials.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
